共 23 条
[1]
Development of daptomycin for gram-positive infections. Tally F P,DeBruin M F. Journal of Antimicrobial Chemotherapy . 2000
[2]
Comparative in vitro activities of daptomycin and vancommycin against resistant gram-positive pathogens. Snydman DR,Jacobus NV,McDermott,et al. Antimicrobial Agents and Chemotherapy . 2000
[3]
In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline(GAR-936). Petersen P J,Jacobus N V,Weiss W J,et al. Antimicrobial Agents and Chemotherapy . 1999
[4]
Antimicrobial resistance with Streptococcus pneumoniae in the United States,1997-98. Doern G V,Brueggemann A B,Huynh H,et al. Emerging Infectious Diseases . 1999
[5]
Efficacy of telithromycin(HMR3647),a new ketolide antimicrobial, in community-acquired pnenmonia caused by atypical pathogens. Leray B,Manickam R. . 2000
[6]
Activity of linezolid against multi-resistant Gram-positive bacteria from diverse hospitals in the United Kingdom. Johnson A P,Warner M,Livermore D M. Journal of Antimicrobial Chemotherapy . 2000
[7]
Quinupristin/dalfopristin and linezolid: where,when, which and whether to use?. Livermore DM. Journal of Antimicrobial Chemotherapy . 2000
[8]
Nosocomial Bloodstream infection in United States hospitals: a three-year analysis. Edmond M B,Wallace S E,MacClish D K,et al. Clinical Infectious Diseases . 1999
[9]
LY-333328. Johnson AP. Curr Opin Anti-infect Invest Drugs . 1999
[10]
HMR 3647, a new ketolide antimicrobial, is metabolized, and excreted mainly in faeces in man. Sultan E,Namour F,Mauriac C,et al. Journal of Antimicrobial Chemotherapy . 1999